Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / GENOMIC ADV ETF
-
Total 13F shares
-
273,604
-
Share change
-
+193,985
-
Total reported value
-
$14,313,683
-
Price per share
-
$52.30
-
Number of holders
-
10
-
Value change
-
+$10,169,153
-
Number of buys
-
5
-
Number of sells
-
5
Institutional Holders of FRANKLIN TEMPLETON ETF TR - GENOMIC ADV ETF (HELX) as of Q3 2021
As of 30 Sep 2021,
FRANKLIN TEMPLETON ETF TR - GENOMIC ADV ETF (HELX) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
273,604 shares.
The largest 10 holders included
Beaumont Financial Partners, LLC, ADVISOR GROUP HOLDINGS, INC., COMMONWEALTH EQUITY SERVICES, LLC, Cambridge Investment Research Advisors, Inc., American Portfolios Advisors, FLOW TRADERS U.S. LLC, BENJAMIN F. EDWARDS & COMPANY, INC., HARBOUR INVESTMENTS, INC., Spire Wealth Management, and Geneos Wealth Management Inc..
This page lists
10
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.